Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | PLAU | P00749 | 2/20 | 0.59 |
| ▸ | MASP2 | O00187 | 1/20 | 0.59 |
| ▸ | THPO | P40225 | 1/20 | 0.59 |
| ▸ | F2 | P00734 | 7/20 | 0.59 |
| ▸ | PRSS1 | P07477 | 4/20 | 0.59 |
| ▸ | PRSS3 | P35030 | 4/20 | 0.59 |
| ▸ | ST14 | Q9Y5Y6 | 3/20 | 0.59 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.59 |
| ▸ | TMPRSS6 | Q8IU80 | 1/20 | 0.58 |
| ▸ | APEX1 | P27695 | 1/20 | 0.56 |
| ▸ | F10 | P00742 | 4/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | BLM | P54132 | 2/20 | 0.55 |
| ▸ | F12 | P00748 | 1/20 | 0.55 |
| ▸ | F7 | P08709 | 1/20 | 0.55 |
| ▸ | F3 | P13726 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8652339 | 0.97 | F2 (0.61) | LMNAPLAUMASP2THPOF2 | |
| Hydrochloric Acid SCHEMBL1483999 | 0.97 | F2 (0.61) | LMNAPLAUMASP2THPOF2 | |
| Acetic Acid SCHEMBL5901032 | 0.91 | NQO2 (0.61) | LMNAPLAUMASP2THPOF2 | |
| Hydrochloric Acid SCHEMBL8994023 | 0.89 | PARP15 (0.59) | LMNAPLAUMASP2THPOF2 | |
| SCHEMBL537030 | 0.85 | LMNA (0.77) | LMNAPLAUMASP2THPOF2 | |
| Terephthalamide SCHEMBL23774 | 0.85 | PARP1 (0.71) | LMNACYP2C19HSD17B10BLMPOLB | |
| Terephthalamide SCHEMBL15328883 | 0.82 | PARP1 (0.67) | LMNACYP2C19HSD17B10BLMPOLB | |
| Terephthalamide SCHEMBL11512422 | 0.82 | PARP1 (0.67) | LMNACYP2C19HSD17B10BLMPOLB | |
| Terephthalamide SCHEMBL7508927 | 0.82 | PARP1 (0.67) | LMNACYP2C19HSD17B10BLMPOLB | |
| Terephthalamide SCHEMBL1906838 | 0.82 | PARP1 (0.67) | LMNACYP2C19HSD17B10BLMPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 520 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119836101-A | Perovskite solar cell based on diamine molten salt surface modification and preparation method thereof | 东方电气长三角(杭州)创新研究院有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-118513038-A | Hydrofining catalyst and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-08-20 | — | — | CN | claimed |
| EP-2796112-B2 | Degradable implantable medical devices | ELIXIR MEDICAL CORP (US) | 2023-08-09 | — | — | EP | claimed |
| WO-2022217521-A1 | COVALENT BOND-LINKED TIO2@CTF‑PY HETEROJUNCTION MATERIAL, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 苏州大学 | 2022-10-20 | — | — | WO | claimed |
| CN-112321782-B | Crystalline covalent triazine organic framework material and preparation method and application thereof | 华中科技大学 | 2021-12-03 | — | — | CN | claimed |
| CN-112321782-A | Crystalline covalent triazine organic framework material and preparation method and application thereof | 华中科技大学 | 2021-02-05 | — | — | CN | claimed |
| US-10350093-B2 | Degradable implantable medical devices | ELIXIR MEDICAL CORPORATION (US) | 2019-07-16 | — | — | US | claimed |
| CN-104146795-B | Degradable implantable medical devices | 万能医药公司 | 2017-11-10 | — | — | CN | claimed |
| EP-3225216-A1 | DEGRADABLE IMPLANTABLE MEDICAL DEVICES | Elixir Medical Corporation (US) | 2017-10-04 | — | — | EP | claimed |
| EP-2796112-B1 | Degradable implantable medical devices | ELIXIR MEDICAL CORP (US) | 2016-11-16 | — | — | EP | claimed |
| EP-1549247-A1 | DRUG RELEASE FROM ANTITHROMBOGENIC MULTI-LAYER COATED STENT | Mediplex Corporation (KR) | 2005-07-06 | — | — | EP | claimed |
| EP-1539762-A2 | BICYCLIC PYRIMIDINONES AS COAGULATION CASCADE INHIBITORS | Bristol-Myers Squibb Company (US) | 2005-06-15 | — | — | EP | claimed |
| WO-2004028406-A1 | DRUG RELEASE FROM ANTITHROMBOGENIC MULTI-LAYER COATED STENT | MEDIPLEX CORPORATION (KR) | 2004-04-08 | — | — | WO | claimed |
| US-6702850-B1 | Multi-coated drug-eluting stent for antithrombosis and antirestenosis | MEDIPLEX CORPORATION KOREA (KR) | 2004-03-09 | — | — | US | claimed |
| WO-2004002406-A2 | BICYCLIC PYRIMIDINONES AS COAGULATION CASCADE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-01-08 | — | — | WO | claimed |
| CN-1117569-C | Bicyclic fibrinogen antagonists | SMITHKLINE BEECHAM CORP (US) | 2003-08-13 | — | — | CN | claimed |
| US-6106866-A | ANTITUMOR AGENTS AND DERMATAN SULFATE | ACCESS PHARMACEUTICALS, INC. (US) | 2000-08-22 | — | — | US | claimed |
| EP-0794796-A1 | COMPLEXES OF DERMATAN SULFATE AND DRUGS, GIVING IMPROVED PHARMACOKINETICS | Access Pharmaceuticals, Inc. (US) | 1997-09-17 | — | — | EP | claimed |
| WO-1996019242-A1 | COMPLEXES OF DERMATAN SULFATE AND DRUGS, GIVING IMPROVED PHARMACOKINETICS | ACCESS PHARMACEUTICALS, INC. (US) | 1996-06-27 | — | — | WO | claimed |
| US-5519024-A | CELL ADHESION INHIBITOR | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-05-21 | — | — | US | claimed |